Evolus to Report Fourth Quarter and Year End 2020 Results and Provide Business Update

Rhea-AI Summary

Evolus, Inc. (NASDAQ: EOLS) will report its fourth quarter and year-end 2020 financial results on March 24, 2021. The company will hold a conference call at 4:30 p.m. ET to discuss these results and provide a business update. A question and answer session will follow management remarks. Domestic callers can dial (866) 916-2317, while international callers should use (703) 925-2662, with a conference ID of 7378855. A replay will be accessible until March 31, 2021. A live audio webcast will be available on the Evolus investor relations page and archived for 30 days.

NEWPORT BEACH, Calif., March 23, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced today that it will report its fourth quarter and year end 2020 financial results and provide a business update conference call and live audio webcast on Wednesday, March 24, 2021.

Management will host a conference call and live webcast to discuss Evolus’ financial results at 4:30 p.m. ET. A question and answer session will follow management remarks.

The dial-in numbers for the conference call are (866) 916-2317 for domestic callers and (703) 925-2662 for international callers.  The conference ID is 7378855.

A replay of the call will be available following its completion through March 31, 2021. To access the replay, dial (855) 859-2056 for domestic callers and (404) 537-3406 for international callers and use the replay conference ID 7378855.

A live audio webcast of the call will be available on the Investor Relations page of the Evolus, Inc. website, https://investors.evolus.com. A replay of the webcast will be archived on Evolus' website for 30 days following the completion of the call.

About Evolus, Inc.

Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. In 2019, the U.S. Food and Drug Administration approved Jeuveau^® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure™ technology. Jeuveau^® is powered by Evolus' unique technology platform and is designed to transform the aesthetic market by eliminating the friction points existing for customers today. Visit us at: http://www.evolus.com.

Jeuveau^® is a registered trademark of Evolus, Inc.

Hi-Pure™ is a trademark of Daewoong Pharmaceutical Co, Ltd.

Evolus, Inc. Contacts:

Investor Contact:

Ashwin Agarwal
Vice President, Finance, Investor Relations & Treasury
Tel: +1-949-284-4559
Email: IR@Evolus.com   

Media Contact:

Crystal Muilenburg
Chief Marketing Officer
Tel: +1-949-284-4506
Email: media@evolus.com 

FAQ

What are the financial results Evolus (EOLS) will report on March 24, 2021?

Evolus is set to announce its fourth quarter and full year 2020 financial results on March 24, 2021.

What time is the Evolus (EOLS) conference call on March 24, 2021?

The Evolus conference call will take place at 4:30 p.m. ET on March 24, 2021.

How can I listen to the Evolus (EOLS) financial results call?

You can join the Evolus conference call by dialing (866) 916-2317 for domestic or (703) 925-2662 for international callers.

Will there be a replay of the Evolus (EOLS) conference call?

Yes, a replay of the Evolus conference call will be available until March 31, 2021.

Where can I find the webcast for the Evolus (EOLS) earnings call?

The live audio webcast can be found on the Evolus investor relations page at their official website.